NCT02372357View on ClinicalTrials.gov

A New Dosing Regimen for Posaconazole Prophylaxis in Children Based on Body Surface Area

PHASE4CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

August 31, 2014

Study Completion Date

October 31, 2014

Conditions
Hematological Malignancy
Interventions
DRUG

Posaconazole prophylaxis 120 mg/m² tid

Patients are receiving posaconazole to prevent invasive fungal infections in a dose of 120 mg/m² tid

PROCEDURE

Blood sampling

During steady state treatment with posaconazole (at least 7 days), 9 blood samples are taken via a central venous catheter to evaluate the pharmacokinetics of posaconazole.

Trial Locations (2)

3000

Catholic University Leuven - Department of Pharmaceutical and Pharmacological Sciences, Leuven

023808

Institutul Clinic Fundeni, Bucharest

All Listed Sponsors
collaborator

Institutul Clinic Fundeni

OTHER

lead

Universitaire Ziekenhuizen KU Leuven

OTHER

NCT02372357 - A New Dosing Regimen for Posaconazole Prophylaxis in Children Based on Body Surface Area | Biotech Hunter | Biotech Hunter